Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:721-729
Published online before print February 9, 2007, doi: 10.1161/01.RES.0000260180.42709.29
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/5/721    most recent
01.RES.0000260180.42709.29v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jasmin, J.-F.
Right arrow Articles by Lisanti, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jasmin, J.-F.
Right arrow Articles by Lisanti, M. P.
Related Collections
Right arrow Angiogenesis
Right arrow Cerebrovascular disease/stroke
Right arrow Pathology of Stroke
(Circulation Research. 2007;100:721.)
© 2007 American Heart Association, Inc.


Integrative Physiology

Caveolin-1 Deficiency Increases Cerebral Ischemic Injury

Jean-François Jasmin*, Samit Malhotra*, Manjeet Singh Dhallu, Isabelle Mercier, Daniel M. Rosenbaum, Michael P. Lisanti

From the Departments of Molecular Pharmacology and Medicine (J.-F.J., M.P.L.), Albert Einstein College of Medicine, Bronx, NY; Department of Cancer Biology (J.-F.J., I.M., M.P.L.), Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pa; Department of Neurology (S.M., M.S.D., D.M.R.), Albert Einstein College of Medicine, Bronx, NY; Department of Neurology (S.M., D.M.R.), SUNY Downstate Medical Center, Brooklyn, NY.

Correspondence to Michael P. Lisanti MD, PhD, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, Bluemle Building, Room 933B, Philadelphia, Pa, 19107. E-mail Michael.Lisanti{at}jefferson.edu

Caveolins (Cav), the principal structural proteins of the caveolar domains, have been implicated in the pathogenesis of ischemic injury. Indeed, changes in caveolin expression and localization have been reported in renal and myocardial ischemia. Genetic ablation of the Cav-1 gene in mice was further shown to increase the extent of ischemic injury in a model of hindlimb ischemia. However, the role of Cav-1 in the pathogenesis of cerebral ischemia remains unknown. Immunoblot and immunofluorescence analyses of rat brains subjected to middle cerebral artery occlusion revealed marked increases in endothelial Cav-1 and Cav-2 protein levels. To directly assess the functional role of caveolins in the pathogenesis of cerebral ischemic injury, we next investigated the effects of cerebral ischemia in caveolin knockout (KO) mice. Interestingly, Cav-1 KO mice showed a marked increase of cerebral volume of infarction, as compared with wild-type and Cav-2 KO mice. Immunofluorescence analyses showed an increased number of proliferating endothelial cells in wild-type ischemic brains, as compared with Cav-1 KO ischemic brains. Immunoblot analyses of wild-type ischemic brains showed an increase in endothelial nitric oxide synthase protein levels. Conversely, the protein levels of endothelial nitric oxide synthase remained unchanged in Cav-1 KO ischemic brains. TUNEL analysis also showed increased apoptotic cell death in Cav-1 KO ischemic brains, as compared with wild-type ischemic brains. Our findings indicate cerebral ischemia induces a marked increase in endothelial Cav-1 and Cav-2 protein levels. Importantly, genetic ablation of the Cav-1 gene in mice results in increased cerebral volume of infarction. Mechanistically, Cav-1 KO ischemic brains showed impaired angiogenesis and increased apoptotic cell death.


Key Words: caveolin • cerebral ischemia • angiogenesis • apoptosis




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S.-H. Chang, D. Feng, J. A. Nagy, T. E. Sciuto, A. M. Dvorak, and H. F. Dvorak
Vascular Permeability and Pathological Angiogenesis in Caveolin-1-Null Mice
Am. J. Pathol., October 1, 2009; 175(4): 1768 - 1776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Stamatovic, R. F. Keep, M. M. Wang, I. Jankovic, and A. V. Andjelkovic
Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells
J. Biol. Chem., July 10, 2009; 284(28): 19053 - 19066.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. P. Head, H. H. Patel, Y. M. Tsutsumi, Y. Hu, T. Mejia, R. C. Mora, P. A. Insel, D. M. Roth, J. C. Drummond, and P. M. Patel
Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death
FASEB J, March 1, 2008; 22(3): 828 - 840.
[Abstract] [Full Text] [PDF]